Risk Factors Associated with Post-COVID-19 Conditions Among Diabetes Patients in the United Arab Emirates
Journal of Epidemiology and Global Health,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 20, 2025
Language: Английский
Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative (N3C)
BMJ Open Diabetes Research & Care,
Journal Year:
2025,
Volume and Issue:
13(1), P. e004536 - e004536
Published: Feb. 1, 2025
Introduction
Elevated
glycosylated
hemoglobin
(HbA1c)
in
individuals
with
type
2
diabetes
is
associated
increased
risk
of
hospitalization
and
death
after
acute
COVID-19,
however
the
effect
HbA1c
on
Long
COVID
unclear.
Objective
Evaluate
association
glycemic
control
development
patients
(T2D).
Research
design
methods
We
conducted
a
retrospective
cohort
study
using
electronic
health
record
data
from
National
Cohort
Collaborative.
Our
included
T2D
eight
sites
longitudinal
natural
language
processing
(NLP)
data.
The
primary
outcome
was
or
new-onset
recurrent
symptoms
within
30–180
days
COVID-19.
Symptoms
were
identified
as
keywords
clinical
notes
NLP
respiratory,
brain
fog,
fatigue,
loss
smell/taste,
cough,
cardiovascular
musculoskeletal
symptom
categories.
Logistic
regression
used
to
evaluate
by
range,
adjusting
for
demographics,
body
mass
index,
comorbidities,
medication.
A
COVID-negative
group
control.
Results
Among
7430
COVID-positive
patients,
1491
(20.1%)
developed
symptomatic
COVID,
380
(5.1%)
died.
8%
<10%
(OR
1.20,
95%
CI
1.02
1.41)
≥10%
1.40,
1.14
1.72)
compared
those
6.5%
<8%.
This
not
seen
group.
Higher
levels
symptoms,
especially
respiratory
fog.
There
no
between
following
more
diagnosis
codes.
Conclusion
Poor
(HbA1c≥8%)
people
higher
Notably,
this
rose.
However,
observed
without
history
An
NLP-based
definition
than
codes
should
be
considered
future
studies.
Language: Английский
Unveiling risk factors for post-COVID-19 syndrome development in people with type 2 diabetes
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 11, 2024
Introduction
Post-COVID-19
syndrome
(PCS)
is
a
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
infection-associated
chronic
condition
characterized
by
long-term
violations
of
physical
and
mental
health.
People
with
type
diabetes
(T2D)
are
at
high
risk
for
COVID-19
PCS.
Aim
The
current
study
aimed
to
define
the
predictors
PCS
development
in
people
T2D
further
planning
preventive
measures
improving
patient
outcomes.
Materials
methods
data
were
collected
through
national
survey
targeting
persons
concerning
history
course
signs
symptoms
that
developed
during
or
after
continued
more
than
12
weeks
not
explained
an
alternative
diagnosis.
In
total,
469
patients
from
different
regions
Ukraine
enrolled
study.
Among
them,
227
reported
(main
group),
while
242
did
claim
(comparison
group).
Stepwise
multivariate
logistic
regression
probabilistic
neural
network
(PNN)
models
used
select
independent
factors.
Results
Based
on
data,
8
factors
associated
selected:
newly
diagnosed
(OR
4.86;
95%
CI
2.55–9.28;
p<0.001),
female
sex
1.29;
0.86–1.94;
p=0.220),
severity
1.35
1.05–1.70;
p=0.018),
myocardial
infarction
2.42
1.26–4.64;
p=0.002)
stroke
3.68
1.70–7.96;
p=0.001)
anamnesis,
HbA1c
above
9.2%
2.17
1.37–3.43;
p=0.001),
use
insulin
analogs
2.28
1.31–3.94;
p=0.003)
vs
human
0.67
0.39–1.15;
p=0.146).
Although
obesity
aggravated
severity,
it
impact
development.
ROC
analysis,
8-factor
multilayer
perceptron
(MLP)
model
exhibited
better
performance
(AUC
0.808;
CІ
0.770–0.843),
allowing
prediction
sensitivity
71.4%,
specificity
76%,
PPV
73.6%
NPV
73.9%.
Conclusions
Patients
who
T2D,
had
9.2%,
previous
cardiovascular
cerebrovascular
events,
mechanical
lung
ventilation
Language: Английский
The Impact of COVID-19 Severity on TNF-α and IFN-γ in T2DM Patients' PBMC Monocytes
Dyahati Wahyurini,
No information about this author
Dicky L. Tahapary,
No information about this author
Heri Wibowo
No information about this author
et al.
Journal Of The Indonesian Medical Association,
Journal Year:
2024,
Volume and Issue:
74(2), P. 79 - 90
Published: May 6, 2024
Introduction:
Monocytes
are
very
sensitive
to
changes
in
the
metabolic
environment,
including
hyperglycemia,
such
as
type
2
diabetes
mellitus
(T2DM).
T2DM
is
characterized
by
chronic
low-grade
inflammation
and
becomes
one
COVID-19
comorbid.
TNF-α
IFN-γ
cytokines
often
linked
inflammation,
severity
of
COVID-19,
long
COVID-19.
This
study
aims
analyze
relationship
between
month
post-infection.Methods:
research
an
experimental
at
Integrated
Laboratory
Faculty
Medicine,
Universitas
Indonesia,
for
four
months.
The
total
samples
44
cryotubes
PBMC
(18
26
Non-T2DM)
from
CARAMEL
(COVID-19,
Aging,
Cardiometabolic
Risk
Factors).
PBMCs
were
stimulated
with
inactivated
whole
virions
SARS-CoV-2
incubated
24
hours.
Monocyte
subsets
intracellular
detected
flow
cytometry.Results:
Research
showed
that
group
was
higher
all
subsets.
There
no
significant
difference
non-T2DM
groups.
Based
on
history
MedFI
classic
intermediate
monocytes
differed
significantly
groups
(p
=
0.049
p
0.022).
Further
needed
risk
factors
involved.Conclusion:
monocyte
differences
related
Language: Английский
Retrospective Analysis of the Characteristics of the Post-COVID Period in Patients with Type 2 Diabetes, Infected During Different Variant-Associated Periods of COVID-19
Diabetes Mellitus,
Journal Year:
2024,
Volume and Issue:
27(5), P. 441 - 450
Published: Nov. 20, 2024
BACKGROUND:
Since
the
emergence
of
coronavirus
infection
in
clinical
practice,
particular
attention
has
been
paid
to
its
acute
phase.
However,
date,
direct
and
indirect
impact
on
patients
with
type
2
diabetes
mellitus
after
recovery
from
remains
an
open
question.
OBJECTIVE
:
To
determine
laboratory
features
post-COVID
period
during
different
phases
infection.
MATERIALS
AND
METHODS
A
descriptive
retrospective
study
was
conducted
using
electronic
medical
records
134
who
had
recovered
RESULTS:
The
majority
were
women,
no
significant
differences
age
gender
distribution
across
groups
(p=0.384
p=0.207,
respectively).
During
«Omicron»
period,
there
fewer
comorbidities
hospitalized
compared
other
(p<0.0167).
Regarding
diabetes-related
conditions,
frequent
urination
observed
only
«Alpha»
while
frequency
hypoglycemia,
hyperglycemia,
severity
chronic
kidney
disease,
manifestations
polyneuropathy
did
not
differ
significantly
between
(p>0.0167).
When
examining
newly
diagnosed
diseases,
a
statistically
difference
found
musculoskeletal
disorders
(16.7%
vs.
30.2%
«Delta»
3.7%
«Omicron»,
p=0.015).
In
analysis
indicators,
detected
platelet
counts
activated
partial
thromboplastin
time
(APTT):
median
lower
group
(210
[179.2–249.7]
x10⁹/L
218
[196.5–281]
255
[208–327]
x10⁹/L,
respectively,
p=0.016).
APTT
longer
for
(28
[23.6–31.3]
seconds
30.3
[26.1–34.9]
27.1
[22.4–30.3]
seconds,
p=0.013).
CONCLUSION
Real-world
data
allow
tracking
development
new
symptoms
diseases
period.
Patients
variant-associated
risk
developing
diseases.
It
is
necessary
implement
solutions
monitoring
target
HbA1c
levels
through
information
systems
enhance
reporting
standards
patient
enable
more
accurate
Real
world
(RWD).
Language: Английский
Implication of iron overload in COVID-19 pathogenesis and long COVID: a mechanistic review
Future Virology,
Journal Year:
2024,
Volume and Issue:
19(14-15), P. 525 - 538
Published: Oct. 12, 2024
COVID-19
causes
cytokine
storm
which
results
in
altered
iron
homeostasis
within
the
system.
The
negative
consequences
of
this
include
poor
metabolism,
ROS-induced
oxidative
damage,
ferroptosis,
and
increased
severity
along
with
illnesses
like
anemia,
thalassemia,
diabetes,
cancer,
neurological
disorders,
long
COVID.
Therefore,
managing
overload
natural
or
synthetic
chelators
alternative
therapeutics
can
help
to
reduce
COVID-19.
This
review
analyzes
intricate
molecular
mechanism
dynamics
during
SARS-CoV-2
infection
disease
progression
patients
related
clinical
consequences.
Also,
explores
a
comprehensive
understanding
reciprocal
between
their
adverse
effects,
thereby
facilitating
development
potential
therapeutic
interventions.
Language: Английский